Active	Status	Sponsor type	Region	Phase	Filter
42 Active 27 Inactive 69 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ulrich, Silvia
ESRA, NCT05339087: Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH	Recruiting	2	70	Europe	Riociguat Oral Tablet, MK-4836, ATC Code: C02KX05, Placebo	Heidelberg University, Merck Sharp & Dohme LLC	Pulmonary Vascular Disorder, Primary Pulmonary Hypertension, Systemic Sclerosis, Other Systemic Involvement of Connective Tissue	10/25	06/26
NCT05610631: Pulmonary Hypertension Registry Switzerland	Recruiting	N/A	1000	Europe		University of Zurich, Actelion	Pulmonary Hypertension	12/27	12/27
Curioni-Fontecedro, Alessandra
A2A-005, NCT05403385: Study of Inupadenant (EOS100850) with Chemotherapy As Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer	Recruiting	2	186	Europe, Canada, US, RoW	inupadenant, EOS100850, Placebo, Carboplatin, Pemetrexed, Alimta	iTeos Therapeutics, iTeos Belgium SA	Metastatic NSCLC - Non-Small Cell Lung Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer	04/25	05/25
Ritter, Alexander
No trials found
Hoyos, Rodrigo Pesanez
No trials found
Huber, Simone
No trials found